logo

For the Inventor, By the Inventor

Menlo Park, CA, United States of America

Mikhail L Gishizky

This inventor holds 9 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Sugen Incorporated, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , New York University. Active years: 2000-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikhail L Gishizky. Retrieved from https://idiyas.com/inventor/mikhail-l-gishizky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 55.6


Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 116(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2000 - 2006)
  • Menlo Park, CA (US) (2005 - 2011)

Company Filing History:

goldMedal6 out of 157 
 
Sugen Incorporated
 patents
silverMedal2 out of 1,335 
 
Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V.
 patents
bronzeMedal2 out of 1,729 
 
New York University
 patents
4. 1 out of 2,085 
 
Duke University
 patents
5. 3 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2011

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 7871786 - GEF-H1b: biomarkers, complexes, assays and therapeutic uses thereof (2011-01-18),
2. 7439329 - GEF-H1b: biomarkers, complexes assays and therapeutic uses thereof (2008-10-21),
3. 7037677 - Megakaryocytic protein tyrosine kinase I (2006-05-02),
4. 6908984 - Megakaryocytic protein tyrosine kinase I (2005-06-21),
5. 6861442 - PYK2 and inflammation (2005-03-01),
6. 6528270 - Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions (2003-03-04),
7. 6506578 - Nucelotide encoding megakaryocytic protein tyrosine kinases (2003-01-14),
8. 6326469 - Megakaryocytic protein tyrosine kinases (2001-12-04),
9. 6066463 - Method and compositions for treatment of BCR-ABL associated leukemias (2000-05-23),

Title: Mikhail L Gishizky: Innovator in Biomarkers and Therapeutics

Introduction

Mikhail L Gishizky is a prominent inventor based in Menlo Park, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of biomarkers and therapeutic applications. With a total of 9 patents to his name, Gishizky's work has the potential to impact the diagnosis and treatment of various diseases.

Latest Patents

Among his latest patents is the invention titled "GEF-H1b: biomarkers, complexes, assays and therapeutic uses thereof." This invention focuses on diagnosing abnormal cell proliferation in biological samples. It also involves screening for drugs that can inhibit, reduce, or abolish cell growth, especially tumorigenic cell growth. The detection of a phosphovariant isoform of a guanine nucleotide exchange factor biomarker, such as the novel GEF-H1S, is a key aspect of this innovation.

Career Highlights

Throughout his career, Gishizky has worked with various companies, including Sugen Incorporated. His expertise in the field has led to numerous advancements in biotechnology and therapeutic development.

Collaborations

Gishizky has collaborated with notable professionals in the industry, including Axel Ullrich and Irmingard Sures. These collaborations have further enhanced his research and contributions to the field.

Conclusion

Mikhail L Gishizky is a distinguished inventor whose work in biomarkers and therapeutics continues to shape the landscape of biotechnology. His innovative patents and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…